AFL vs IDYA · P/E 14, rev $4.12B vs rev $15.4M
Aflac Incorporated (AFL) versus Ideaya Biosciences Inc (IDYA) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported IDYA revenue for 2026-06-30 was $15.4M. Net income was -$211.0M. IDYA currently screens at market cap $2.96B.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. IDYA currently screens at market cap $2.96B.
Not investment advice. Open the AFL and IDYA stock pages for the full models.
Not investment advice.